Date 29 July 2025

Highnoon Laboratories Limited (HINOON) has entered into a strategic partnership with Bangladesh-based Beximco Pharmaceuticals to distribute and market specialised drugs in Pakistan.

A memorandum of understanding (MoU) was signed to focus on high-burden therapeutic areas such as respiratory, diabetes, and cardiovascular diseases.

The collaboration aims to introduce innovative therapies, advanced dosage forms, and improved drug delivery systems for better clinical outcomes.

This alliance also supports growing trade ties between Pakistan and Bangladesh in the healthcare sector.